Healthmode

HealthMode, Inc. (healthmode.com) powers next-generation clinical trials and works toward regulatory approval and market access for drugs, devices, and combination products by developing and delivering AI-enabled digital measurement methods for clinical trials and clinical care.

HealthMode’s client partners represent a diverse set of stakeholders including drug developers at large pharmaceutical companies, clinical researchers and practitioners at academic medical centers, and startups entering the space with novel capabilities.

HealthMode’s measurement techniques:
- Improve understanding of phenotype
- Streamline and provide assurance for screening and eligibility;
- Provide early detection and mitigation of adverse events; and
- Serve as sensitive, specific, objective, and low burden endpoints.

The HealthMode approach allows for meaningful integration of clinical trial data with real-world evidence and provides the basis for movement toward a patient-specific understanding of health and wellness.